Medicamen Biotech Limited — Others, 30-06-2025: Trading Window

Medicamen Biotech Limited has announced a board meeting to approve the financial results for the quarter and half-year ending June 30, 2025. The company has closed its trading window for all directors and designated persons from July 1, 2025, until 48 hours after the results are publicly declared. This trading restriction aims to prevent any insider trading ahead of the financial disclosure, ensuring transparency and fairness for shareholders.